R Pharm:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:R Pharm - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10618
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ロシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
R Pharm is a pharmaceutical company that develops and manufactures medicinal products. The company offers finished dosage forms, active pharmaceutical ingredients and biotechnological substances. It offers products in the therapeutic areas of oncology, hematology, immune diseases, antibiotics, antivirals, neurology, cardiology, multiple sclerosis, hemophilia and diabetes, among others. R Pharm also carries out research and development of products and technologies, introduction of advanced medicinal products to the market, and education and training of specialists for the pharmaceutical industry and healthcare. The company supplies medicinal products and laboratory equipment for the hospitals, federal medical research centers, clinical hospitals, and regional curative and preventive care institutions. It has operations in Russia, the US, Turkey and Germany, among others. R-Pharm is headquartered in Moscow, Russia.

R Pharm – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
R Pharm, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
R Pharm, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
R Pharm, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
R Pharm, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
R Pharm, Medical Devices Deals, 2012 to YTD 2018 9
R Pharm, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
R Pharm, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
R-Pharm US Acquires Rights to IXEMPRA from Bristol-Myers Squibb 11
R-Pharm Acquires Production Plant in Illertissen, Germany from Pfizer 12
Partnerships 14
Midatech Pharma US Enters into Co-Marketing Agreement with R-Pharm US 14
Ilyang Pharma Enters into Agreement with R-Pharm for Supect 15
R-Pharm Enters into Research Agreement with Nagoya University 16
Scynexis Enters Into Co-Marketing Agreement With R-Pharm For SCY-078 17
R-Pharm Forms Joint Venture 18
R-Pharm Enters Into Co-Marketing Agreement With Boryung Pharma For Kanarb 19
Licensing Agreements 20
R-Pharm Enters into Licensing Agreement with Camurus 20
R-Pharm Enters into Licensing Agreement with Kyorin Pharma for Imidafenacin 21
TaiGen Biotech Enters Into Licensing Agreement With R-Pharm For Nemonoxacin 22
Paion Extends Licensing Agreement with R-Pharm for Remimazolam for MENA Region 23
Paion Enters Into Licensing Agreement With R-Pharm For Remimazolam 24
Paion Extends Licensing Agreement With R-Pharm For Remimazolam 25
UCB Enters Into Licensing Agreement With R-Pharm For Olokizumab 26
Theravance Enters Into Licensing Agreement With R-Pharm For TD-1792 And Telavancin 27
R-Pharm Enters into Licensing Agreement with Eli Lilly 28
R-Pharm Enters Into Licensing Agreement With Merck For Narlaprevir 29
Bristol-Myers Squibb Enters into Licensing Agreement with R-Pharm 30
Amgen Enters Into Licensing Agreement With R-Pharm 31
Equity Offering 32
R-Pharm Invests USD136 Million in TR-Pharma 32
Acquisition 33
R-Pharm to Acquire 51% Stake in SIA International 33
R Pharm – Key Competitors 34
R Pharm – Key Employees 35
R Pharm – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
R Pharm, Pharmaceuticals & Healthcare, Key Facts 2
R Pharm, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
R Pharm, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
R Pharm, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
R Pharm, Deals By Therapy Area, 2012 to YTD 2018 8
R Pharm, Medical Devices Deals, 2012 to YTD 2018 9
R Pharm, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
R-Pharm US Acquires Rights to IXEMPRA from Bristol-Myers Squibb 11
R-Pharm Acquires Production Plant in Illertissen, Germany from Pfizer 12
Midatech Pharma US Enters into Co-Marketing Agreement with R-Pharm US 14
Ilyang Pharma Enters into Agreement with R-Pharm for Supect 15
R-Pharm Enters into Research Agreement with Nagoya University 16
Scynexis Enters Into Co-Marketing Agreement With R-Pharm For SCY-078 17
R-Pharm Forms Joint Venture 18
R-Pharm Enters Into Co-Marketing Agreement With Boryung Pharma For Kanarb 19
R-Pharm Enters into Licensing Agreement with Camurus 20
R-Pharm Enters into Licensing Agreement with Kyorin Pharma for Imidafenacin 21
TaiGen Biotech Enters Into Licensing Agreement With R-Pharm For Nemonoxacin 22
Paion Extends Licensing Agreement with R-Pharm for Remimazolam for MENA Region 23
Paion Enters Into Licensing Agreement With R-Pharm For Remimazolam 24
Paion Extends Licensing Agreement With R-Pharm For Remimazolam 25
UCB Enters Into Licensing Agreement With R-Pharm For Olokizumab 26
Theravance Enters Into Licensing Agreement With R-Pharm For TD-1792 And Telavancin 27
R-Pharm Enters into Licensing Agreement with Eli Lilly 28
R-Pharm Enters Into Licensing Agreement With Merck For Narlaprevir 29
Bristol-Myers Squibb Enters into Licensing Agreement with R-Pharm 30
Amgen Enters Into Licensing Agreement With R-Pharm 31
R-Pharm Invests USD136 Million in TR-Pharma 32
R-Pharm to Acquire 51% Stake in SIA International 33
R Pharm, Key Competitors 34
R Pharm, Key Employees 35
R Pharm, Other Locations 36
R Pharm, Subsidiaries 37
R Pharm, Joint Venture 37

List of Figures
R Pharm, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
R Pharm, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
R Pharm, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
R Pharm, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
R Pharm, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
R Pharm, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
R Pharm, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
R Pharm, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
R Pharm, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[R Pharm:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nakheel:企業の戦略・SWOT・財務情報
    Nakheel - Strategy, SWOT and Corporate Finance Report Summary Nakheel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Academia Sinica:製薬・医療:M&Aディール及び事業提携情報
    Summary Academia Sinica is an academic institution that promotes and undertakes research activities in the disciplines of mathematics and physical sciences, life sciences, humanities and social sciences, and others. The institution integrates research activities to improve the planning, implementati …
  • Asatsu-DK Inc. (9747):企業の財務・戦略的SWOT分析
    Asatsu-DK Inc. (9747) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Capitol Health Ltd (CAJ):医療機器:M&Aディール及び事業提携情報
    Summary Capitol Health Ltd (Capitol Health) is a diagnostic imaging service provider to the healthcare market.. The company offers services such as bone densitomety, computer tomography, cone beam CT, CT angiography, doppler, echocardiography, fluoroscopy, general X-ray, magnetic resonance imaging, …
  • Great Wall Motor Co Ltd:企業の戦略・SWOT・財務分析
    Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • C&D Technologies Inc:企業の戦略的SWOT分析
    C&D Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Nissan Chemical Corporation:企業の戦略・SWOT・財務分析
    Nissan Chemical Corporation - Strategy, SWOT and Corporate Finance Report Summary Nissan Chemical Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Mexco Energy Corp (MXC):石油・ガス:M&Aディール及び事業提携情報
    Summary Mexco Energy Corp (Mexco Energy) is an oil and gas company that offers exploration, acquisition, production, and development of crude oil, natural gas, condensate liquids, and natural gas liquids. The company acquires producing and non-producing oil and gas leases from landowners and leaseho …
  • Fubon Financial Holding Co Ltd:戦略・SWOT・企業財務分析
    Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Fubon Financial Holding Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • HICL Infrastructure Co Ltd:企業のM&A・事業提携・投資動向
    HICL Infrastructure Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HICL Infrastructure Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Oneida Ltd.:企業の戦略的SWOT分析
    Oneida Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Kirby Corporation:企業の戦略・SWOT・財務情報
    Kirby Corporation - Strategy, SWOT and Corporate Finance Report Summary Kirby Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • First American Financial Corporation:企業のM&A・事業提携・投資動向
    First American Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First American Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • Obuv Rossii OOO (OBUV):企業の財務・戦略的SWOT分析
    Obuv Rossii OOO (OBUV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ACHP Plc:企業の戦略・SWOT・財務情報
    ACHP Plc - Strategy, SWOT and Corporate Finance Report Summary ACHP Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Sprouts Farmers Market Inc (SFM):企業の財務・戦略的SWOT分析
    Sprouts Farmers Market Inc (SFM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • North Eastern Electric Power Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary North Eastern Electric Power Corporation Limited (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and sola …
  • China Resources Gas Group Ltd (1193):企業の財務・戦略的SWOT分析
    China Resources Gas Group Ltd (1193) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Seneca Biopharma Inc (CUR):企業の財務・戦略的SWOT分析
    Summary Seneca Biopharma Inc(Seneca) formerly known as Neuralstem Inc, is a biopharmaceutical company that develops novel treatments for nervous system diseases. The company offers cell therapy treatment for ALS, ischemic stroke, spinal cord injury, multiple sclerosis, optic neuritis, Alzheimer’s di …
  • Saudi Electricity Co:発電所・企業SWOT分析
    Saudi Electricity Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆